# PREGABALIN
> **ANDA214322** · Abbreviated New Drug Application (Generic) · Sponsor: CHANGZHOU PHARM · Approved 2021-07-15
## Drug
- **FDA Application Number:** ANDA214322
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PREGABALIN
- **Generic name:** PREGABALIN
- **Active ingredients:** PREGABALIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHANGZHOU PHARM
- **Manufacturer:** Tris Pharma Inc
- **First approval:** 2021-07-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214322)
---
*AI Analytics · CC0 1.0*